7/31/2019 2012Influvac Product Presentation

1/22

PROTECT YOUR WORLD

and you!

7/31/2019 2012Influvac Product Presentation

2/22

Are you influvaccinated?

your family

your teammate

your employees

your organization

YOUR WORLD?

7/31/2019 2012Influvac Product Presentation

3/22

Our world is one BIG FAMILY!

7/31/2019 2012Influvac Product Presentation

4/22

Protection from Influenza

Influenza is a highly contagious

respiratory infection brought

about by virus and its commonly

known asFLU or TRANGKASO

Ranked as the 4th leading cause of morbidity in thePhilippines after pneumonia.

7/31/2019 2012Influvac Product Presentation

5/22

7/31/2019 2012Influvac Product Presentation

6/22

3-4 days illness, followed by weeks of fatigue

and feeling under the weather

the need to take time off work

severe interference in everyday life

medical complications for those suffering from

asthma leading to pneumonia or other deadly

illnesses

INFLUENZA can lead to:

7/31/2019 2012Influvac Product Presentation

7/22

FLU can leave your business paralyzedand costs companies considerable money

each year because of:

Absenteeism

Presenteeism

Replacement and overtime cost

Interruption of services and delivery

Lost of productivity and sales

Increased healthcare cost

7/31/2019 2012Influvac Product Presentation

8/22

Spending time feeling ill with flu is a matter of choice;

Flu could lead to something more serious than

just a week feeling sick...

What kind of opportunities could we lose in a week?

So maybe flu vaccination is more of a benefit than

actually an obligation...

7/31/2019 2012Influvac Product Presentation

9/22

PROTECT YOUR WORLD

FLU vaccination remains the cornerstone

of preventing influenza.

The BESTway to prevent flu is toget a flu vaccination each year.

FLU vaccination doesnt protect only you,

it also prevents spreading flu to others.

7/31/2019 2012Influvac Product Presentation

10/22

PROTECT YOUR WORKFORCE,

PROTECT YOUR BUSINESS

significant reduction in overall mortality

hospitalisation for cardiac events

hospitalisation for stroke

physicians visit for upper respiratoryillnesses

days of sick leave from work due to upperrespiratory illnesses

work absenteeism due to illnesses

7/31/2019 2012Influvac Product Presentation

11/22

Protect yourself, Protect your loved ones

Chronic respiratory disease, including asthma

Chronic heart disease

Chronic renal disease

Diabetes Mellitus

Immunosuppression due to illness or treatment

Everybody aged 65 years and over, depending on local

guidelines

Groups at high risk for influenza complicationsAdult and children with any of the following risks:

Elderly:

7/31/2019 2012Influvac Product Presentation

12/22

The only Sub-unit Influenza Vaccine with

Dupharject advantage

7/31/2019 2012Influvac Product Presentation

13/22

Historical development in influenza vaccination

7/31/2019 2012Influvac Product Presentation

14/22

has been in the influenza vaccine market for over 60

years with uninterrupted supply

currently available in more than 75 countries

composition complies with WHO guidelines

well-established safety and tolerability profile;

no unexpected adverse events have been reported

convenient to administer with the pre-filled syringe

7/31/2019 2012Influvac Product Presentation

15/22

is a third-generation vaccine with a good safetyprofile and lower rate of reactogenicity than split and

whole virus vaccines1

(1) Beyer WEP, Palache AM, Osterhaus ADME. Clin Drug Invest1998;15:1-12

7/31/2019 2012Influvac Product Presentation

16/22

an A/California/7/2009 (H1N1)pdm09-like virus;

an A/Perth/16/2009 (H3N2)-like virus;

a B/Brisbane/60/2008-like virus.

contains the Southern Hemisphere 2012

Influenza Strain Composition Recommended by the World Health

Organization

STRAINS INCLUDED IN

THE VACCINE

World Health Organization 2012 Guidelines

7/31/2019 2012Influvac Product Presentation

17/22

Influvacs Dupharject System

7/31/2019 2012Influvac Product Presentation

18/22

is administered as a 0.5 ml dose

for children 3 years old and above,

0.25 ml dose in children (635 months of age)

Influvac is not indicated for use in children

7/31/2019 2012Influvac Product Presentation

19/22

EMPLOYEES EDUCATION

Patient Awareness Flyers

Flu Prevention Lecture

DURING VACCINATION

Flexible team of Doctors and

Nurses to conduct on sitevaccination

Hygienic disposal of usedmaterials

AFTER SALES Influcare monitoring card for

employees vaccinedocumentation

INFLUCARE PROGRAM

7/31/2019 2012Influvac Product Presentation

20/22

Advantages of INFLUVAC

SUB-UNIT VACCINE excellent safety profile, lower rate of local and

systemic reactions, ensure lower incidence of unwanted side-effects.

DUPHARJECT SYRINGE SYSTEM ensures nearly painless injection and

offers maximum comfort of administration because of the silicone

coated needle. It has a special seal that is proven to protect against

microbial contamination, both during storage and upon injection(absence of reflux, rigid needle guard)

INFLUCARE PROGRAM complete program before, during and after

vaccination.To access the cost-benefit calculator for influenza vaccination in workplace,

visit www.influtec.com.

7/31/2019 2012Influvac Product Presentation

21/22

PROTECT YOUR WORKFORCE,

PROTECT YOUR BUSINESS

Because every organization is one

BIG FAMILY!

Be INFLUVACcinated!

7/31/2019 2012Influvac Product Presentation

22/22

Thank you